What Is Bacteriostatic Water? Composition, Benzyl Alcohol and Storage

'Bacteriostatic' means growth-inhibiting, not sterilising. The preservative is there because a multiple-dose container is entered repeatedly. In FDA terminology, a multiple-dose container is one that has met antimicrobial effectiveness testing requirements — testing that asks whether the product prevents microbial growth if contamination occurs during use.^[7]

The US test behind this, USP chapter <51>, first became official in 1970 and was later refined to measure the preservative system as protection against inadvertent contamination during storage and use. Its European Pharmacopoeia counterpart regards a preservative as suitable when, after a deliberate challenge with test organisms, their numbers show a significant reduction or no increase at defined time points.^[8][2]

The effect takes time. In a 1982 hospital study, multiple-dose vials containing bacteriostatic agents were deliberately inoculated with E. coli and Pseudomonas aeruginosa: bacteria could still be recovered when samples were taken within an hour, one product was still positive at 16 hours, and none was positive after that. Benzyl alcohol's activity also varies: it is more active against Gram-negative bacteria than against Gram-positive bacteria or fungi, works best at acidic pH, and has little effect above pH 8.^[9][2]

Benzyl alcohol is an aromatic alcohol (C7H8O). In medicinal products it serves as a preservative, as a solubilising agent and, on the skin, as a fragrance; in the body it is metabolised to benzoic acid. A 2007 review found phenol and benzyl alcohol to be the two most common preservatives in licensed peptide and protein products; a 2023 count, weighted by the many insulin products, put m-cresol first and benzyl alcohol third.^[12][6][2]

Its antimicrobial action is membrane-directed: benzyl alcohol increases membrane fluidity and interferes with bacterial membrane functions such as efflux pumps. It is not inert towards everything it meets in solution either — certain preservatives have been reported to increase particle formation by proteins and peptides, which is the subject of the next section.^[2]

Benzyl alcohol also has a documented toxicity history. In 1982, US reports linked it to neonatal deaths and to a fatal 'gasping syndrome' in premature infants, and EMA's excipient guidance names accumulation in newborns, whose metabolism is immature, as the main safety concern. That history explains the warnings on products that contain it — and is one more reason to treat bacteriostatic water as a laboratory material with a defined composition rather than a neutral liquid.^[14][13][12]

Sterile water for injection is the unpreserved version. An FDA-approved label describes it as a sterile, nonpyrogenic preparation that contains no bacteriostat, antimicrobial agent or added buffer and is supplied only in single-dose containers — with the instruction not to reuse them and to discard any unused portion.^[10]

The difference is about the container's life, not about purity. A single-dose container is not required to pass antimicrobial effectiveness testing and is designed for one use; a multiple-dose container has met that testing — either inherently or through an added preservative — and may be entered again. Bacteriostatic water is the multiple-dose option: licensed freeze-dried products supplied with it are described as yielding a multi-dose solution.^[7][2]

European pharmacopoeial language differs again. The Ph. Eur. grades include water for injections — which, as 'sterilised water for injections', is the grade for dissolving or diluting parenteral preparations — and purified water, intended for preparations that need not be sterile and apyrogenic. Since 2017 the Ph. Eur. monograph (0169) also allows water for injections to be produced by processes equivalent to distillation, such as reverse osmosis combined with other techniques. 'Distilled' therefore names a production method, not a pharmacopoeial grade.^[11]

Not automatically. Formulation scientists select a preservative on three criteria — the amount needed, its antimicrobial function and its effect on the active ingredient — and check that last point with techniques such as circular dichroism, fluorescence and calorimetry. FDA-approved diluent labels carry the same caution: some compounds are incompatible in a vehicle containing benzyl alcohol.^[6][10]

Most of the published evidence concerns proteins. With recombinant interferon-gamma, 0.9% benzyl alcohol altered tertiary structure and produced high-molecular-weight aggregates, to a degree that depended on protein concentration, buffer and preservative level. With recombinant interleukin-1 receptor antagonist (rhIL-1ra), benzyl alcohol bound weakly to the protein and favoured partially unfolded, aggregation-prone forms; sucrose partly counteracted the effect.^[4][5]

The dissolving step is where the effect showed most clearly. Freeze-dried rhIL-1ra dissolved in 0.9% benzyl alcohol aggregated more than the same material dissolved in water — up to 21% soluble aggregate in the least concentrated formulation — and the extent tracked how much native structure had survived freeze-drying. During later storage at room temperature, benzyl alcohol did not accelerate aggregation further.^[3][2]

Peptide-specific data are thinner. In a model-peptide study summarised in the 2023 review, rising peptide concentration weakened the antimicrobial efficacy of three preservatives in the Ph. Eur. test, with benzyl alcohol the least affected. We found no comparable compatibility data for most research peptides, so compatibility has to be treated as compound-specific rather than assumed.^[2]

Unopened, a pharmacopoeial diluent is stored as its label directs, up to the printed expiry date. For comparison, the FDA-approved sterile water label cited above specifies controlled room temperature (20–25 °C) and 'do not freeze', and says the solution should not be used unless it is clear and the seal is intact.^[10]

Once opened, the clock starts. FDA guidance states that the beyond-use date of an opened or entered — for example, needle-punctured — multiple-dose container is 28 days unless the manufacturer's label specifies otherwise, and that any different period should be supported by data and printed on the label. In a lab, that makes the date of first entry worth writing on the vial.^[7]

The preservative itself changes over time. Benzyl alcohol slowly oxidises in air to benzaldehyde and then benzoic acid. It is also taken up by some plastics: a 2% solution in polyethylene lost 15% of its benzyl alcohol over 13 weeks at 20 °C, and in another comparison at 40 °C losses approached 80% in low-density polyethylene against under 10% in polypropylene. Natural, neoprene and butyl rubber closures slowly adsorb it too — reasons to keep the solution in its original closed container rather than decanting it into other plastics.^[2]

It is a solvent choice, not a quality credential: it says nothing about the identity, purity or content of the peptide dissolved in it. Those questions are answered by the peptide's own batch documentation — a certificate that names the lot, the methods and the laboratory.

Peptyds supplies its compounds for laboratory research only; they are not sold for human or veterinary use. The step-by-step of dissolving a lyophilised peptide, and the concentration arithmetic, live in the reconstitution guide and calculator rather than being repeated here.